Sebaceous Neoplasms

Sebaceous neoplasms are a spectrum of skin growths, from benign to malignant, that arise from abnormal proliferation of oil-producing cells (sebocytes). Identifying them correctly matters not only for treating the lesion itself but also because they can be the first clue to an underlying inherited condition such as Muir-Torre syndrome.

Structural Features of Sebaceous Neoplasms

Sebaceous neoplasms fall into four main types, based on how differentiated the cells are and the proportion of mature sebocytes to basaloid cells:

LesionBiological natureClinical significance
Sebaceous hyperplasiaBenign enlargementCommon in older adults; pale yellow papules with a central dip on the face.
Sebaceous adenomaBenign neoplasmThe most important marker of Muir-Torre syndrome.
Sebaceoma (sebaceous epithelioma)Benign / borderline neoplasmEasily mistaken for basal cell carcinoma; also linked to Muir-Torre syndrome.
Sebaceous carcinoma (SC)Malignant tumorHighly malignant; prone to recurrence and to spread to lymph nodes and internal organs.

Treatment Strategy and Clinical Management at Haute-Derma

Surgery

  • Mohs micrographic surgery (MMS): The treatment of choice (gold standard) for sebaceous carcinoma, particularly around the eye. Mohs surgery checks 100% of the margins on fresh tissue, cuts the local recurrence rate to under 5% and preserves as much of the eyelid's vital anatomy as possible.
  • Wide local excision (WLE): Used when Mohs surgery is not available, with a minimum safety margin of 5–6 mm and intraoperative frozen-section margin control.

Sentinel Node Assessment and Systemic Treatment

  • Sentinel lymph node biopsy (SLNB): Considered for periocular sebaceous carcinoma larger than 10 mm, tumors with a high mitotic rate or vascular/perineural invasion, and recurrent disease.
  • Radiotherapy: Given as adjuvant treatment after surgery when tumor cells remain at the margins and further surgery is not possible, or as palliative treatment for patients who cannot undergo surgery.
  • Immunotherapy: Immune checkpoint inhibitors (such as the anti-PD-1 antibody pembrolizumab) have shown strong results in locally advanced or metastatic sebaceous carcinoma with mismatch repair deficiency (dMSI/dMMR).

Common Sebaceous Neoplasms and Carcinoma

Sebaceous Adenoma

A benign tumor made of differentiated sebaceous lobules in which mature sebocytes predominate. It appears as a pale yellow or pink papule or nodule on the face and is an important skin marker of Muir-Torre syndrome.

Sebaceoma

A benign tumor with sebaceous differentiation, made up mainly of immature germinative cells. It presents as a raised yellow or skin-colored papule or nodule on the head and face.

Sebaceous Carcinoma

A dangerous malignant tumor of the sebaceous glands, most often the meibomian glands of the eyelid. It shows as a firm, painless yellow nodule that is easily mistaken for a recurrent chalazion or stye, and it can invade deeply and frequently spreads to lymph nodes.

Frequently Asked Questions (FAQs)

Experiencing similar symptoms?

Our Haute-Derma specialists are ready to provide expert consultation on Sebaceous Neoplasms — from accurate diagnosis to the most suitable treatment plan for you.

Same-day appointments · Confidential · Minimal wait time

Nhắn tin cho phòng khám

Để lại lời nhắn, tư vấn viên sẽ gọi lại cho bạn trong giờ làm việc. Kênh này không dùng cho tình trạng khẩn cấp: nếu có dấu hiệu nguy hiểm, hãy gọi 115.

Gọi 0329 279 889